Hornerin, an S100 family protein, is functional in breast cells and aberrantly expressed in breast cancer

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Fleming, Jodie M ^a,b   Ginsburg, Erika ^b   Oliver, Shannon D ^a   Goldsmith, Paul ^b   Vonderhaar, Barbara K ^b  

^a NORTH CAROLINA CENTRAL UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Apoptosis; Breast cancer; Hornerin; Mammary gland; Protein fragmentation; S100 protein

Indexed keywords

HORNERIN PROTEIN; PROTEIN S 100; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CELL; BREAST EPITHELIUM; CARBOXY TERMINAL SEQUENCE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; EXOSOME; EXTRACELLULAR MATRIX; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LUNG CARCINOMA; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEOMICS; TRANSMISSION ELECTRON MICROSCOPY; TUMOR BIOPSY; WESTERN BLOTTING; WOUND HEALING;

ANIMALS; BREAST NEOPLASMS; CALCIUM-BINDING PROTEINS; CELL DEATH; CELL LINE, TUMOR; EXOSOMES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERMEDIATE FILAMENT PROTEINS; MAMMARY GLANDS, ANIMAL; MAMMARY GLANDS, HUMAN; MICE; NEOPLASM STAGING; PROTEIN TRANSPORT; PROTEOLYSIS; S100 PROTEINS;

EID: 84862537086     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-266     Document Type: Article

References (49)

1. Carafoli E. Calcium signaling: a tale for all seasons. Proc Natl Acad Sci USA 2002, 99(3):1115-1122. 10.1073/pnas.032427999, 122154, 11830654.
2. Leclerc E, Heizmann CW. The importance of Ca2+/Zn2+ signaling S100 proteins and RAGE in translational medicine. Front Biosci (Schol Ed) 2011, 3:1232-1262.
3. Berridge MJ, Bootman MD, Roderick HL. Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 2003, 4(7):517-529. 10.1038/nrm1155, 12838335.
4. Heizmann CW, Ackermann GE, Galichet A. Pathologies involving the S100 proteins and RAGE. Subcell Biochem 2007, 45:93-138. 10.1007/978-1-4020-6191-2_5, 18193636.
5. McKiernan E, McDermott EW, Evoy D, Crown J, Duffy MJ. The role of S100 genes in breast cancer progression. Tumour Biol 2011, 32(3):441-450. 10.1007/s13277-010-0137-2, 21153724.
6. Barraclough R. Calcium-binding protein S100A4 in health and disease. Biochim Biophys Acta 1998, 1448(2):190-199. 10.1016/S0167-4889(98)00143-8, 9920410.
7. Emberley ED, Niu Y, Leygue E, Tomes L, Gietz RD, Murphy LC, Watson PH. Psoriasin interacts with Jab1 and influences breast cancer progression. Cancer Res 2003, 63(8):1954-1961.
8. Emberley ED, Murphy LC, Watson PH. S100A7 and the progression of breast cancer. Breast Cancer Res 2004, 6(4):153-159. 10.1186/bcr816, 468668, 15217486.
9. Liu D, Rudland PS, Sibson DR, Platt-Higgins A, Barraclough R. Expression of calcium-binding protein S100A2 in breast lesions. Br J Cancer 2000, 83(11):1473-1479. 10.1054/bjoc.2000.1488, 2363420, 11076656.
10. Feng G, Xu X, Youssef EM, Lotan R. Diminished expression of S100A2, a putative tumor suppressor, at early stage of human lung carcinogenesis. Cancer Res 2001, 61(21):7999-8004.
11. Fleming JM, Miller TC, Quinones M, Xiao Z, Xu X, Meyer MJ, Ginsburg E, Veenstra TD, Vonderhaar BK. The normal breast microenvironment of premenopausal women differentially influences the behavior of breast cancer cells in vitro and in vivo. BMC Med 2010, 8:27. 10.1186/1741-7015-8-27, 2894739, 20492690.
12. Makino T, Takaishi M, Morohashi M, Huh NH. Hornerin, a novel profilaggrin-like protein and differentiation-specific marker isolated from mouse skin. J Biol Chem 2001, 276(50):47445-47452. 10.1074/jbc.M107512200, 11572870.
13. Wu Z, Meyer-Hoffert U, Reithmayer K, Paus R, Hansmann B, He Y, Bartels J, Glaser R, Harder J, Schroder JM. Highly complex peptide aggregates of the S100 fused-type protein hornerin are present in human skin. J Invest Dermatol 2009, 129(6):1446-1458. 10.1038/jid.2008.370, 19020553.
14. Henry J, Hsu CY, Haftek M, Nachat R, de Koning HD, Gardinal-Galera I, Hitomi K, Balica S, Jean-Decoster C, Schmitt AM, et al. Hornerin is a component of the epidermal cornified cell envelopes. FASEB J 2011, 25(5):1567-1576. 10.1096/fj.10-168658, 21282207.
15. Takaishi M, Makino T, Morohashi M, Huh NH. Identification of human hornerin and its expression in regenerating and psoriatic skin. J Biol Chem 2005, 280(6):4696-4703.
16. Hovey RC, Trott JF, Vonderhaar BK. Establishing a framework for the functional mammary gland: from endocrinology to morphology. J Mammary Gland Biol Neoplasia 2002, 7(1):17-38. 10.1023/A:1015766322258, 12160083.
17. Panchal H, Wansbury O, Parry S, Ashworth A, Howard B. Neuregulin3 alters cell fate in the epidermis and mammary gland. BMC Dev Biol 2007, 7:105. 10.1186/1471-213X-7-105, 2110892, 17880691.
18. Hislop NR, Caddy J, Ting SB, Auden A, Vasudevan S, King SL, Lindeman GJ, Visvader JE, Cunningham JM, Jane SM. Grhl3 and Lmo4 play coordinate roles in epidermal migration. Dev Biol 2008, 321(1):263-272. 10.1016/j.ydbio.2008.06.026, 18619436.
19. Singh RR, Barnes CJ, Talukder AH, Fuqua SA, Kumar R. Negative regulation of estrogen receptor alpha transactivation functions by LIM domain only 4 protein. Cancer Res 2005, 65(22):10594-10601. 10.1158/0008-5472.CAN-05-2268, 16288053.
20. Santner SJ, Dawson PJ, Tait L, Soule HD, Eliason J, Mohamed AN, Wolman SR, Heppner GH, Miller FR. Malignant MCF10CA1 cell lines derived from premalignant human breast epithelial MCF10AT cells. Breast Cancer Res Treat 2001, 65(2):101-110. 10.1023/A:1006461422273, 11261825.
21. Fleming JM, Long EL, Ginsburg E, Gerscovich D, Meltzer PS, Vonderhaar BK. Interlobular and intralobular mammary stroma: genotype may not reflect phenotype. BMC Cell Biol 2008, 9:46. 10.1186/1471-2121-9-46, 2529294, 18710550.
22. Staubach S, Razawi H, Hanisch FG. Proteomics of MUC1-containing lipid rafts from plasma membranes and exosomes of human breast carcinoma cells MCF-7. Proteomics 2009, 9(10):2820-2835. 10.1002/pmic.200800793, 19415654.
23. Mathivanan S, Fahner CJ, Reid GE, Simpson RJ. ExoCarta 2012: database of exosomal proteins, RNA and lipids. Nucleic Acids Res 2012, 40(Database issue):D1241-D1244. 3245025, 21989406.
24. Mariner JM, McMahon JB, O'Keefe BR, Nagashima K, Boyd MR. The HIV-inactivating protein, cyanovirin-N, does not block gp120-mediated virus-to-cell binding. Biochem Biophys Res Commun 1998, 248(3):841-845. 10.1006/bbrc.1998.9060, 9704015.
25. Belanger JM, Raviv Y, Viard M, de la Cruz JM, Nagashima K, Blumenthal R. Characterization of the effects of aryl-azido compounds and UVA irradiation on the viral proteins and infectivity of human immunodeficiency virus type 1. Photochem Photobiol 2010, 86(5):1099-1108. 10.1111/j.1751-1097.2010.00780.x, 2974757, 20630026.
26. Ahn YH, Lee JY, Kim YS, Ko JH, Yoo JS. Quantitative analysis of an aberrant glycoform of TIMP1 from colon cancer serum by L-PHA-enrichment and SISCAPA with MRM mass spectrometry. J Proteome Res 2009, 8(9):4216-4224. 10.1021/pr900269s, 19645485.
27. Dumont D, Noben JP, Raus J, Stinissen P, Robben J. Proteomic analysis of cerebrospinal fluid from multiple sclerosis patients. Proteomics 2004, 4(7):2117-2124. 10.1002/pmic.200300715, 15221773.
28. Looze C, Yui D, Leung L, Ingham M, Kaler M, Yao X, Wu WW, Shen RF, Daniels MP, Levine SJ. Proteomic profiling of human plasma exosomes identifies PPARgamma as an exosome-associated protein. Biochem Biophys Res Commun 2009, 378(3):433-438. 10.1016/j.bbrc.2008.11.050, 2633355, 19028452.
29. Graner MW, Alzate O, Dechkovskaia AM, Keene JD, Sampson JH, Mitchell DA, Bigner DD. Proteomic and immunologic analyses of brain tumor exosomes. FASEB J 2009, 23(5):1541-1557. 10.1096/fj.08-122184, 2669426, 19109410.
30. Monks J, Henson PM. Differentiation of the mammary epithelial cell during involution: implications for breast cancer. J Mammary Gland Biol Neoplasia 2009, 14(2):159-170. 10.1007/s10911-009-9121-0, 19408104.
31. Soule HD, Maloney TM, Wolman SR, Peterson WD, Brenz R, McGrath CM, Russo J, Pauley RJ, Jones RF, Brooks SC. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res 1990, 50(18):6075-6086.
32. Dawson PJ, Wolman SR, Tait L, Heppner GH, Miller FR. MCF10AT: a model for the evolution of cancer from proliferative breast disease. Am J Pathol 1996, 148(1):313-319. 1861604, 8546221.
33. Miller FR, Soule HD, Tait L, Pauley RJ, Wolman SR, Dawson PJ, Heppner GH. Xenograft model of progressive human proliferative breast disease. J Natl Cancer Inst 1993, 85(21):1725-1732. 10.1093/jnci/85.21.1725, 8411256.
34. Basolo F, Elliott J, Tait L, Chen XQ, Maloney T, Russo IH, Pauley R, Momiki S, Caamano J, Klein-Szanto AJ, et al. Transformation of human breast epithelial cells by c-Ha-ras oncogene. Mol Carcinog 1991, 4(1):25-35. 10.1002/mc.2940040106, 2009132.
35. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, Clark L, Bayani N, Coppe JP, Tong F, et al. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell 2006, 10(6):515-527. 10.1016/j.ccr.2006.10.008, 2730521, 17157791.
36. Jin Q, Chen H, Luo A, Ding F, Liu Z. S100A14 stimulates cell proliferation and induces cell apoptosis at different concentrations via receptor for advanced glycation end products (RAGE). PLoS One 2011, 6(4):e19375. 10.1371/journal.pone.0019375, 3084824, 21559403.
37. Ghavami S, Eshragi M, Ande SR, Chazin WJ, Klonisch T, Halayko AJ, McNeill KD, Hashemi M, Kerkhoff C, Los M. S100A8/A9 induces autophagy and apoptosis via ROS-mediated cross-talk between mitochondria and lysosomes that involves BNIP3. Cell Res 2010, 20(3):314-331. 10.1038/cr.2009.129, 19935772.
38. Lefevre CM, Sharp JA, Nicholas KR. Evolution of lactation: ancient origin and extreme adaptations of the lactation system. Annu Rev Genomics Hum Genet 2010, 11:219-238. 10.1146/annurev-genom-082509-141806, 20565255.
39. McKeague AL, Wilson DJ, Nelson J. Staurosporine-induced apoptosis and hydrogen peroxide-induced necrosis in two human breast cell lines. Br J Cancer 2003, 88(1):125-131. 10.1038/sj.bjc.6600675, 2376787, 12556971.
40. Petersson S, Bylander A, Yhr M, Enerback C. S100A7 (Psoriasin), highly expressed in ductal carcinoma in situ (DCIS), is regulated by IFN-gamma in mammary epithelial cells. BMC Cancer 2007, 7:205. 10.1186/1471-2407-7-205, 2180183, 17986321.
41. Kennedy RD, Gorski JJ, Quinn JE, Stewart GE, James CR, Moore S, Mulligan K, Emberley ED, Lioe TF, Morrison PJ, et al. BRCA1 and c-Myc associate to transcriptionally repress psoriasin, a DNA damage-inducible gene. Cancer Res 2005, 65(22):10265-10272. 10.1158/0008-5472.CAN-05-1841, 16288014.
42. Ewing RM, Chu P, Elisma F, Li H, Taylor P, Climie S, McBroom-Cerajewski L, Robinson MD, O'Connor L, Li M, et al. Large-scale mapping of human protein-protein interactions by mass spectrometry. Mol Syst Biol 2007, 3:89. 1847948, 17353931.
43. Zhou XZ. PinX1: a sought-after major tumor suppressor at human chromosome 8p23. Oncotarget 2011, 2(10):810-819. 3248153, 22021332.
44. van Niel G, Porto-Carreiro I, Simoes S, Raposo G. Exosomes: a common pathway for a specialized function. J Biochem 2006, 140(1):13-21. 10.1093/jb/mvj128, 16877764.
45. Srikrishna G, Freeze HH. Endogenous damage-associated molecular pattern molecules at the crossroads of inflammation and cancer. Neoplasia 2009, 11(7):615-628. 2697348, 19568407.
46. Lacroix M, Leclercq G. Relevance of breast cancer cell lines as models for breast tumours: an update. Breast Cancer Res Treat 2004, 83(3):249-289. 10.1023/B:BREA.0000014042.54925.cc, 14758095.
47. Fillatre J, Delacour D, Van Hove L, Bagarre T, Houssin N, Soulika M, Veitia RA, Moreau J. Dynamics of the subcellular localization of RalBP1/RLIP through the cell cycle: the role of targeting signals and of protein-protein interactions. FASEB J 2012,
48. Mueller A, Bachi T, Hochli M, Schafer BW, Heizmann CW. Subcellular distribution of S100 proteins in tumor cells and their relocation in response to calcium activation. Histochem Cell Biol 1999, 111(6):453-459. 10.1007/s004180050381, 10429967.
49. Cross SS, Hamdy FC, Deloulme JC, Rehman I. Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers. Histopathology 2005, 46(3):256-269. 10.1111/j.1365-2559.2005.02097.x, 15720411.